Resmed produces sleep apnoea machines and accompanying technology in Singapore and Australia, and the $49bn company confirmed this week its existing tariff exemption will continue in the US.

Sleep device maker ResMed says it has received an exemption from Donald Trump’s trade tariffs, meaning exports from its manufacturing hubs in Australia and Singapore can dodge the US president ...

The ResMed share price was trading at around $40 in late January. Since then, it's dropped by about 12%, with ResMed shares now changing hands for about $35 each.

The ResMed share price hasn’t escaped recent market volatility. Is it time to buy? The post Why I'm taking a closer look at ResMed shares appeared first on The Motley Fool Australia.

Editor's note: It's important to remember that not every Apple Watch Series 10 device will have these problems. In fact, you might not come across any issues at all.

Windows 10 PCs that are still being used in the corporate sector are also experiencing printer problems. Windows Latest quotes one user as saying: “Our clients got KB5053606 yesterday and most ...

I'm keeping a close eye on the ResMed Inc (ASX: RMD) share price. There is a lot to like about ResMed, and with the share ...

ResMed: Helping millions with sleep apnea, COPD, and related issues to live better lives; View Product. ResMed AirFit P30i Frame System - Replacement CPAP Frame System with Nasal Pillows Cushion - ...

Summary. ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices ...

ResMed’s ASX-traded securities edged 1 per cent higher to $40.06 on the result. Shares in the company have increased by 36 per cent in the past 12 months after the popularity of weight-loss ...